Oncoproteomics: current trends and future perspectives

References

• Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis18, 533–537 (1997).
   PubMed Web of Science ®Google Scholar
• Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature402, 715–720 (1999).
   PubMedGoogle Scholar
• Xiao Z, Prieto D, Conrads TP et al. Proteomic patterns: their potential for disease diagnosis. Mol. Cell. Endocrinol.230(1–2), 95–106 (2005).
   PubMed Web of Science ®Google Scholar
• Cho WC. Proteomics – leading biological science in the 21st Century. Sci. J.56(5), 14–17 (2004).
   Google Scholar
• O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem.250, 4007–4021 (1975).
   PubMed Web of Science ®Google Scholar
• Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik26(3), 231–243 (1975).
   PubMedGoogle Scholar
• Gygi SP, Corthals GL, Zhang Y et al. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl Acad. Sci. USA97(17), 9390–9395 (2000).
   PubMed Web of Science ®Google Scholar
• Bjellqvist B, Ek K, Righetti PG et al. Isoelectric focusing in immobilized pH gradients: principle, methodology and some applications. J. Biochem. Biophys. Methods6(4), 317–339 (1982).
   PubMedGoogle Scholar
• Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics4(12), 3665–3685 (2004).
   PubMed Web of Science ®Google Scholar
• Nilsson CL, Larsson T, Gustafsson E et al. Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry. Anal. Chem.72, 2148–2153 (2000).
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Peptidomics for cancer diagnosis: present and future. J. Proteome Res.5(9), 2079–2082 (2006).
   PubMed Web of Science ®Google Scholar
• Shen YF, Smith RD. Advanced nanoscale separations and mass spectrometry for sensitive high-throughput proteomics. Expert Rev. Proteomics2(3), 431–447 (2005).
   PubMed Web of Science ®Google Scholar
• Qian WJ, Jacobs JM, Liu T et al. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell. Proteomics5(10), 1727–1744 (2006).
   PubMed Web of Science ®Google Scholar
• Min HK, Hyung SW, Shin JW et al. Ultrahigh-pressure dual online solid phase extraction/capillary reversed-phase liquid chromatography/tandem mass spectrometry (DO-SPE/cRPLC/MS/MS): a versatile separation platform for high-throughput and highly sensitive proteomic analyses. Electrophoresis28(6), 1012–1021 (2007).
   Google Scholar
• Guo T, Lee CS, Wang W et al. Capillary separations enabling tissue proteomics-based biomarker discovery. Electrophoresis27(18), 3523–3532 (2006).
   Google Scholar
• Hoffman SA, Joo WA, Echan LA et al. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.849(1–2), 43–52 (2007).
   PubMed Web of Science ®Google Scholar
• Marcus K, Schafer H, Klaus S et al. A new fast method for nanoLC-MALDI-TOF/TOF-MS analysis using monolithic columns for peptide preconcentration and separation in proteomic studies. J. Proteome Res.6(2), 636–643 (2007).
   Google Scholar
• Imami K, Monton MR, Ishihama Y et al. Simple on-line sample preconcentration technique for peptides based on dynamic pH junction in capillary electrophoresis-mass spectrometry. J. Chromatogr. A.1148(2), 250–255 (2007).
   Google Scholar
• Hu Q, Cooks RG, Noll RJ. Phase-enhanced selective ion ejection in an Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom.18(6), 980–983 (2007).
   Google Scholar
• Venable JD, Wohlschlegel J, McClatchy DB et al. Relative quantification of stable isotope labeled peptides using a linear ion trap-Orbitrap hybrid mass spectrometer. Anal. Chem.79(8), 3056–3064 (2007).
   PubMed Web of Science ®Google Scholar
• Macek B, Waanders LF, Olsen JV et al. Top-down protein sequencing and MS3 on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer. Mol. Cell. Proteomics5(5), 949–958 (2006).
   PubMed Web of Science ®Google Scholar
• Lim MS, Elenitoba-Johnson KS. Proteomics in pathology research. Lab. Invest.84, 1227–1244 (2004).
   PubMed Web of Science ®Google Scholar
• Everley PA, Bakalarski CE, Elias JE et al. Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation. J. Proteome Res.5(5), 1224–1231 (2006).
   PubMed Web of Science ®Google Scholar
• Adachi J, Kumar C, Zhang Y et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol.7(9), R80 (2006).
   PubMed Web of Science ®Google Scholar
• Melanson JE, Chisholm KA, Pinto DM. Targeted comparative proteomics by liquid chromatography/matrix-assisted laser desorption/ionization triple-quadrupole mass spectrometry. Rapid Commun. Mass Spectrom.20(5), 904–910 (2006).
   PubMed Web of Science ®Google Scholar
• Liu H, Sadygov RG, Yates JR III. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem.76(14), 4193–4201 (2004).
   PubMed Web of Science ®Google Scholar
• Ishihama Y, Oda Y, Tabata T et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics4(9), 1265–1272 (2005).
   PubMed Web of Science ®Google Scholar
• Mayya V, Rezual K, Wu L et al. Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin-dependent kinases. Mol. Cell. Proteomics5(6), 1146–1157 (2006).
   PubMed Web of Science ®Google Scholar
• Yu Z, Weinberger PM, Sasaki C et al. Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol. Biomarkers Prev.16(3), 553–558 (2007).
   PubMed Web of Science ®Google Scholar
• Cho WC. Research progress in SELDI-TOF MS and its clinical applications. Chin. J. Biotechnol.22(6), 871–876 (2006).
   Google Scholar
• Issaq HJ, Veenstra TD, Conrads TP et al. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun.292, 587–592 (2002).
   PubMed Web of Science ®Google Scholar
• Yanagisawa K, Shyr Y, Xu BJ et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet362(9382), 433–439 (2003).
   PubMed Web of Science ®Google Scholar
• Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J. Am. Dent. Assoc.137(3), 313–321 (2006).
   PubMed Web of Science ®Google Scholar
• Fung ET, Thulasiraman V, Weinberger SR et al. Protein biochips for differential profiling. Curr. Opin. Biotechnol.12, 65–69 (2001).
   PubMed Web of Science ®Google Scholar
• Henderson NA, Steele RJ. SELDI-TOF proteomic analysis and cancer detection. Surgeon3(6), 383–390, 422 (2005).
   Google Scholar
• Ajikumar PK, Ng JK, Tang YC et al. Carboxyl-terminated dendrimer-coated bioactive interface for protein microarray: high-sensitivity detection of antigen in complex biological samples. Langmuir23(10), 5670–5677 (2007).
   PubMed Web of Science ®Google Scholar
• Xu R, Gan X, Fang Y et al. A simple, rapid, and sensitive integrated protein microarray for simultaneous detection of multiple antigens and antibodies of five human hepatitis viruses (HBV, HCV, HDV, HEV, and HGV). Anal. Biochem.362(1), 69–75 (2007).
   PubMed Web of Science ®Google Scholar
• Song S, Li B, Wang L et al. A cancer protein microarray platform using antibody fragments and its clinical applications. Mol. Biosyst.3(2), 151–158 (2007).
   PubMedGoogle Scholar
• Pepe MS, Cai T, Longton G. Combining predictors for classification using the area under the receiver operating characteristic curve. Biometrics62(1), 221–229 (2006).
   PubMed Web of Science ®Google Scholar
• Fung ET, Enderwick C. ProteinChip clinical proteomics: computational challenges and solutions. BioTechniques Suppl.34–38, 40–41 (2002).
   Google Scholar
• Zhang X, Lu X, Shi Q et al. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinformatics7, 197 (2006).
   PubMed Web of Science ®Google Scholar
• Wang Y, Hanley R, Klemke RL. Computational methods for comparison of large genomic and proteomic datasets reveal protein markers of metastatic cancer. J. Proteome Res.5(4), 907–915 (2006).
   Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24(8), 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Kraljevic S, Sedic M, Scott M et al. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view? Cancer Treat. Rev.32(8), 619–629 (2006).
   PubMed Web of Science ®Google Scholar
• Nettikadan S, Radke K, Johnson J et al. Detection and quantification of protein biomarkers from fewer than 10 cells. Mol. Cell. Proteomics5(5), 895–901 (2006).
   PubMed Web of Science ®Google Scholar
• Granger J, Siddiqui J, Copeland S et al. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics5(18), 4713–4718 (2005).
   PubMed Web of Science ®Google Scholar
• Omenn GS. Strategies for plasma proteomic profiling of cancers. Proteomics6(20), 5662–5673 (2006).
   PubMed Web of Science ®Google Scholar
• Feuerstein I, Rainer M, Bernardo K et al. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling. J. Proteome Res.4(6), 2320–2326 (2005).
   Google Scholar
• Thulasiraman V, Lin S, Gheorghiu L et al. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis26(18), 3561–3571 (2005).
   PubMed Web of Science ®Google Scholar
• van der Merwe DE, Oikonomopoulou K, Marshall J et al. Mass spectrometry: uncovering the cancer proteome for diagnostics. Adv. Cancer Res.96, 23–50 (2007).
   PubMed Web of Science ®Google Scholar
• Finnskog D, Jaras K, Ressine A et al. High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry. Electrophoresis27(5–6), 1093–1103 (2006).
   Google Scholar
• Bouamrani A, Ternier J, Ratel D et al. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin. Chem.52(11), 2103–2106 (2006).
   PubMed Web of Science ®Google Scholar
• Hwang SI, Thumar J, Lundgren DH et al. Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene26(1), 65–76 (2007).
   PubMed Web of Science ®Google Scholar
• Danna EA, Nolan GP. Transcending the biomarker mindset: deciphering disease mechanisms at the single cell level. Curr. Opin. Chem. Biol.10(1), 20–27 (2006).
   PubMed Web of Science ®Google Scholar
• Irish JM, Kotecha N, Nolan GP. Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat. Rev. Cancer6(2), 146–155 (2006).
   PubMed Web of Science ®Google Scholar
• Griffin JL, Kauppinen RA. Tumour metabolomics in animal models of human cancer. J. Proteome Res.6(2), 498–505 (2007).
   PubMed Web of Science ®Google Scholar
• Fan TW, Lane AN, Higashi RM. The promise of metabolomics in cancer molecular therapeutics. Curr. Opin. Mol. Ther.6(6), 584–592 (2004).
   PubMed Web of Science ®Google Scholar
• Downes MR, Byrne JC, Dunn MJ et al. Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review. Biomarkers11(5), 406–416 (2006).
   PubMed Web of Science ®Google Scholar
• Gogoi R, Srinivasan S, Fishman DA. Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer. Expert Rev. Mol. Diagn.6(4), 627–637 (2006).
   PubMed Web of Science ®Google Scholar
• Cekaite L, Hovig E, Sioud M. Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses. Methods Mol. Biol.360, 335–348 (2007).
   Google Scholar
• Cho WC. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol. Cancer6, 1 (2007).
   PubMed Web of Science ®Google Scholar
• Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer6, 25 (2007).
   PubMed Web of Science ®Google Scholar
• Chuthapisith S, Layfield R, Kerr ID et al. Principles of proteomics and its applications in cancer. Surgeon5(1), 14–22 (2007).
   PubMedGoogle Scholar
• Kikuchi T, Carbone DP. Proteomics analysis in lung cancer: challenges and opportunities. Respirology12(1), 22–28 (2007).
   PubMed Web of Science ®Google Scholar